Telista Trio CL 6.25 Tablet
Marketer
Lupin Ltd
Salt Composition
Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)
Overview Telista Trio CL 6.25 Tablet
Tri-Med CL 6.25 tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation effectively lowers elevated blood pressure, mitigating the risk of future strokes and heart attacks. Administer Tri-Med CL 6.25 with food, at the same time daily, following your physician's prescribed dosage based on your individual response. Continuous use, as directed by your doctor, is crucial. Due to its diuretic component, avoid taking this medication within four hours of bedtime to minimize nighttime urination. Consistent use is essential for optimal results, even during symptom-free periods, as hypertension often presents asymptomatically. Discontinuing treatment may increase stroke or heart attack risk. Common side effects may include edema in the ankles, headaches, dizziness, fatigue, and altered taste perception. Report any persistent, worsening, or bothersome side effects to your doctor immediately. Maintain adequate hydration to counteract potential side effects such as muscle weakness, dry mouth, and thirst. Prior to commencing treatment, inform your doctor of any pre-existing liver or kidney conditions, and if you are pregnant or breastfeeding. Disclose all other medications, particularly those for hypertension or cardiac issues. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is necessary to ensure treatment efficacy.
Primary Ingredients of Telista Trio CL 6.25 Tablet
No information provided. Please provide the text you wish to be rephrased.
Uses of Telista Trio CL 6.25 Tablet
Elevated blood pressure
Major Benefits of Telista Trio CL 6.25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telista Trio CL 6.25 Tablets should be administered with a meal.
Common Side effects of Telista Trio CL 6.25 Tablet:
- Ankle swelling
- Headache
- Dizziness
- Tiredness
- Palpitations
- Sleepiness
- Glucose intolerance
- Taste change
- Flushing (sense of warmth in the face, ears, neck and trunk)
- Upset stomach
- Altered blood lipid level
How to use Telista Trio CL 6.25 Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Telista Trio CL 6.25 Tablet whole; avoid chewing, crushing, or breaking it. Administer this medicine with food.
How Telista Trio CL 6.25 Tablet works:
Telista Trio CL 6.25mg tablets contain telmisartan, cilnidipine, and chlorthalidone, three medications working synergistically to reduce blood pressure. Telmisartan, an angiotensin II receptor antagonist, and cilnidipine, a calcium channel blocker, both promote vasodilation, leading to lower blood pressure. Chlorthalidone, a diuretic, facilitates the excretion of excess fluid and electrolytes, contributing to reduced blood pressure and improved circulation through its vasodilatory effects.
SAFETY ADVICE
AlcoholUNSAFE
Combining Telista Trio CL 6.25 Tablet with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
Using Telista Trio CL 6.25 Tablet during pregnancy is contraindicated due to established risks to the fetus. Nevertheless, a physician might exceptionally prescribe it in life-threatening emergencies where potential benefits outweigh the hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Telista Trio CL 6.25 Tablet with breastfeeding is currently lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving may be impaired by Telista Trio CL 6.25 Tablet, as it can induce drowsiness, visual disturbances, and dizziness. Refrain from operating a vehicle if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Telista Trio CL 6.25mg tablets, as dose modification may be necessary. A physician's consultation is advised; this medication is generally not recommended for such patients.
LiverCAUTION
Patients with liver impairment should use Telista Trio CL 6.25 mg tablets cautiously, potentially requiring a modified dosage. Medical advice is recommended. Telista Trio CL 6.25 mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Telista Trio CL 6.25 Tablet :
Should you forget a Telista Trio CL 6.25 Tablet dose, take it immediately. If your next dose is imminent, however, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Telista Trio CL 6.25 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |





